Ali Sayed Arbab, MBBS, PhD, received a 2-year subcontract to conduct research pertaining to an NCI/NIH R21

Ali Arbab, MD, PhD
Ali Arbab, MD, PhD
Ali Arbab, MD, PhD
Ali Arbab, MD, PhD
Ali Arbab, MD, PhD
Ali Arbab, MD, PhD
Ali Sayed Arbab, MBBS, PhD, received a 2-year subcontract to conduct research pertaining to an NCI/NIH R21, “MRI of magnetically labeled immune/stem cells for early tumor detection (PQC5),” awarded to the University of Michigan.
Description: The ability to detect very small tumors (104 – 105 cells; 0.001 – 0.01 mm3), 2-3 orders of magnitude smaller than currently possible, would have a profound impact on cancer treatment. The Arbab laboratory’s unique and innovative approach for detection of cancer is to use MRI to track the infiltration of magnetically labeled monocytes and mesenchymal stem cells into very small tumors. While this proposal focuses on glioma, successful completion of this project opens up the possibility of using this methodology for detection of multiple cancer types in other anatomical locations.

Written by
Allison Brown
View all articles
Leave a reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Written by Allison Brown

About Jagwire

Jagwire is the official source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia. Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences. Have a story to share with Jaguar Nation? Contact the Division of Communications & Marketing.